Jagsonpal Pharmaceuticals share news, announcements and annual reports
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Jagsonpal Pharmaceuticals Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1987 on BSE, Mar 2000 on NSE
Last close ₹216.09down ₹5.85 (2.64%)BSE ₹216.90
Share price at the NSE close on 30 Oct 2026. Previous close ₹221.94.
30 Oct: open ₹222.00, high ₹226.64, low ₹212.58
52-week range of traded prices to 30 Oct 2026
₹155.00Low, 22 Jan 2026₹264.50High, 30 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,427 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 5.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.85%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 71,54749.3% delivered
Jagsonpal Pharmaceuticals record dates, bonuses and splits
23 filed, newest first.
Jul 2026
29 Jul · Corporate action
Apr 2026
27 Apr · Corporate action
Jul 2025
26 Jul · Corporate action
Dec 2024
17 Dec · Corporate action
Oct 2024
Aug 2024
7 Aug · Corporate action
Aug 2023
8 Aug · Corporate action
May 2022
Oct 2021
20 Oct · Corporate action
Sep 2021
7 Sep · Corporate action
Sep 2020
5 Sep · Corporate action
Aug 2017
14 Aug · Corporate action
Register of Members and Share Transfer Books of the Company shall remain closed from September 23, 2017 to September 29, 2017 (both days inclusive) for the purpose of Declaration of dividend and annual general meeting.
Aug 2016
Sep 2014
8 Sep · Corporate action
Register of Members and Share Transfer Books of the Company shall remain closed from September 27, 2014 to September 30, 2014 (both days inclusive) for the purpose of Dividend of Re. 0.50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2014 and for the purpose of Annual General Meeting.
Sep 2013
4 Sep · Corporate action
Company has fixed Book Closure from September 27, 2013 to September 30, 2013 for the purpose of Dividend of Rs. .50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2013 and for the purpose of Annual General Meeting.
Sep 2012
7 Sep · Corporate action
Company has announced the Book Closure from September 25, 2012 to September 28, 2012 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2012 and for the purpose of Annual General Meeting.
Sep 2011
7 Sep · Corporate action
Company has announced the Book Closure from September 27, 2011 to September 30, 2011 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2011 and for the purpose of Annual General Meeting.
Sep 2010
7 Sep · Corporate action
Register of Members and Share Transfer Books shall remain closed from September 23, 2010 to September 25, 2010 (both days inclusive) for the purpose of dividend of Rs. 0.50 only (Paisa Fifty only) per equity share of Rs. 5/- each for the Financial Year ended March 31, 2010 and for the purpose of Annual General Meeting.
Sep 2009
7 Sep · Corporate action
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Company has announced the Book Closure from September 25, 2009 to September 30, 2009 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.25 only (Paisa Twenty Five only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2009 and for the purpose of Annual General Meeting.
Sep 2008
1 Sep · Corporate action
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Book Closure is from September 26, 2008 to September 29, 2008 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.10 only (Paisa 10 only) per Equity Shares of Rs 5/- each for the Financial Year March 31, 2008 and for the purpose of Annual General Meeting.
Aug 2007
29 Aug · Corporate action
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Company has announced book closure from September 25, 2007 to September 29, 2007 (both days inclusive) for the purpose of dividend of Rs. 0.10 only (Paisa Ten Only) Per Equity Share of Rs. 5/- each for the financial year ended March 31, 2007 and for the purpose of Annual General Meeting.